BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ross D, Siegel D. NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase), functions and pharmacogenetics. Methods Enzymol 2004;382:115-44. [PMID: 15047100 DOI: 10.1016/S0076-6879(04)82008-1] [Cited by in Crossref: 176] [Cited by in F6Publishing: 90] [Article Influence: 9.8] [Reference Citation Analysis]
Number Citing Articles
1 Zheng S, Byrd AS, Fischer BM, Grover AR, Ghio AJ, Voynow JA. Regulation of MUC5AC expression by NAD(P)H:quinone oxidoreductase 1. Free Radic Biol Med 2007;42:1398-408. [PMID: 17395013 DOI: 10.1016/j.freeradbiomed.2007.01.040] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 1.6] [Reference Citation Analysis]
2 Gaikwad NW, Yang L, Rogan EG, Cavalieri EL. Evidence for NQO2-mediated reduction of the carcinogenic estrogen ortho-quinones. Free Radic Biol Med. 2009;46:253-262. [PMID: 18996184 DOI: 10.1016/j.freeradbiomed.2008.10.029] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 2.9] [Reference Citation Analysis]
3 Thapa D, Huang SB, Muñoz AR, Yang X, Bedolla RG, Hung CN, Chen CL, Huang TH, Liss MA, Reddick RL, Miyamoto H, Kumar AP, Ghosh R. Attenuation of NAD[P]H:quinone oxidoreductase 1 aggravates prostate cancer and tumor cell plasticity through enhanced TGFβ signaling. Commun Biol 2020;3:12. [PMID: 31909204 DOI: 10.1038/s42003-019-0720-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
4 Gurumurthy M, Rao M, Mukherjee T, Rao SP, Boshoff HI, Dick T, Barry CE 3rd, Manjunatha UH. A novel F(420) -dependent anti-oxidant mechanism protects Mycobacterium tuberculosis against oxidative stress and bactericidal agents. Mol Microbiol 2013;87:744-55. [PMID: 23240649 DOI: 10.1111/mmi.12127] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 6.6] [Reference Citation Analysis]
5 Lim S, Kwon M, Joung EJ, Shin T, Oh CW, Choi JS, Kim HR. Meroterpenoid-Rich Fraction of the Ethanolic Extract from Sargassum serratifolium Suppressed Oxidative Stress Induced by Tert-Butyl Hydroperoxide in HepG2 Cells. Mar Drugs 2018;16:E374. [PMID: 30304831 DOI: 10.3390/md16100374] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
6 Silvers MA, Deja S, Singh N, Egnatchik RA, Sudderth J, Luo X, Beg MS, Burgess SC, DeBerardinis RJ, Boothman DA, Merritt ME. The NQO1 bioactivatable drug, β-lapachone, alters the redox state of NQO1+ pancreatic cancer cells, causing perturbation in central carbon metabolism. J Biol Chem 2017;292:18203-16. [PMID: 28916726 DOI: 10.1074/jbc.M117.813923] [Cited by in Crossref: 41] [Cited by in F6Publishing: 23] [Article Influence: 8.2] [Reference Citation Analysis]
7 Ma X, Huang X, Moore Z, Huang G, Kilgore JA, Wang Y, Hammer S, Williams NS, Boothman DA, Gao J. Esterase-activatable β-lapachone prodrug micelles for NQO1-targeted lung cancer therapy. J Control Release 2015;200:201-11. [PMID: 25542645 DOI: 10.1016/j.jconrel.2014.12.027] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 6.9] [Reference Citation Analysis]
8 Lu F, Zahid M, Wang C, Saeed M, Cavalieri EL, Rogan EG. Resveratrol prevents estrogen-DNA adduct formation and neoplastic transformation in MCF-10F cells. Cancer Prev Res (Phila) 2008;1:135-45. [PMID: 19138946 DOI: 10.1158/1940-6207.CAPR-08-0037] [Cited by in Crossref: 74] [Cited by in F6Publishing: 43] [Article Influence: 5.7] [Reference Citation Analysis]
9 Peng Q, Lu Y, Lao X, Chen Z, Li R, Sui J, Qin X, Li S. The NQO1 Pro187Ser polymorphism and breast cancer susceptibility: evidence from an updated meta-analysis. Diagn Pathol 2014;9:100. [PMID: 24884893 DOI: 10.1186/1746-1596-9-100] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
10 Thorn CF, Oshiro C, Marsh S, Hernandez-Boussard T, McLeod H, Klein TE, Altman RB. Doxorubicin pathways: pharmacodynamics and adverse effects. Pharmacogenet Genomics. 2011;21:440-446. [PMID: 21048526 DOI: 10.1097/fpc.0b013e32833ffb56] [Cited by in Crossref: 657] [Cited by in F6Publishing: 277] [Article Influence: 59.7] [Reference Citation Analysis]
11 Puumala SE, Ross JA, Aplenc R, Spector LG. Epidemiology of childhood acute myeloid leukemia. Pediatr Blood Cancer. 2013;60:728-733. [PMID: 23303597 DOI: 10.1002/pbc.24464] [Cited by in Crossref: 63] [Cited by in F6Publishing: 52] [Article Influence: 7.0] [Reference Citation Analysis]
12 Jiménez-Osorio AS, González-Reyes S, García-Niño WR, Moreno-Macías H, Rodríguez-Arellano ME, Vargas-Alarcón G, Zúñiga J, Barquera R, Pedraza-Chaverri J. Association of Nuclear Factor-Erythroid 2-Related Factor 2, Thioredoxin Interacting Protein, and Heme Oxygenase-1 Gene Polymorphisms with Diabetes and Obesity in Mexican Patients. Oxid Med Cell Longev 2016;2016:7367641. [PMID: 27274779 DOI: 10.1155/2016/7367641] [Cited by in F6Publishing: 18] [Reference Citation Analysis]
13 Zhou H, Dehn D, Kepa JK, Siegel D, Scott DE, Tan W, Ross D. NAD(P)H:quinone oxidoreductase 1-compromised human bone marrow endothelial cells exhibit decreased adhesion molecule expression and CD34+ hematopoietic cell adhesion. J Pharmacol Exp Ther 2010;334:260-8. [PMID: 20378716 DOI: 10.1124/jpet.110.167841] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
14 Panchuk RR, Lehka LV, Terenzi A, Matselyukh BP, Rohr J, Jha AK, Downey T, Kril IJ, Herbacek I, van Schoonhoven S, Heffeter P, Stoika RS, Berger W. Rapid generation of hydrogen peroxide contributes to the complex cell death induction by the angucycline antibiotic landomycin E. Free Radic Biol Med 2017;106:134-47. [PMID: 28189848 DOI: 10.1016/j.freeradbiomed.2017.02.024] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
15 Ross D, Zhou H. Relationships between metabolic and non-metabolic susceptibility factors in benzene toxicity. Chem Biol Interact 2010;184:222-8. [PMID: 19941840 DOI: 10.1016/j.cbi.2009.11.017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
16 Reinhardt CR, Jaglinski TC, Kastenschmidt AM, Song EH, Gross AK, Krause AJ, Gollmar JM, Meise KJ, Stenerson ZS, Weibel TJ, Dison A, Finnegan MR, Griesi DS, Heltne MD, Hughes TG, Hunt CD, Jansen KA, Xiong AH, Hati S, Bhattacharyya S. Insight into the kinetics and thermodynamics of the hydride transfer reactions between quinones and lumiflavin: a density functional theory study. J Mol Model 2016;22:199. [PMID: 27491848 DOI: 10.1007/s00894-016-3074-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Liu Q, Jin Z, Xu Z, Yang H, Li L, Li G, Li F, Gu S, Zong S, Zhou J, Cao L, Wang Z, Xiao W. Antioxidant effects of ginkgolides and bilobalide against cerebral ischemia injury by activating the Akt/Nrf2 pathway in vitro and in vivo. Cell Stress Chaperones 2019;24:441-52. [PMID: 30815818 DOI: 10.1007/s12192-019-00977-1] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 11.0] [Reference Citation Analysis]
18 Rushworth SA, Macewan DJ. The role of nrf2 and cytoprotection in regulating chemotherapy resistance of human leukemia cells. Cancers (Basel) 2011;3:1605-21. [PMID: 24212776 DOI: 10.3390/cancers3021605] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.0] [Reference Citation Analysis]
19 Pandareesh MD, Shrivash MK, Naveen Kumar HN, Misra K, Srinivas Bharath MM. Curcumin Monoglucoside Shows Improved Bioavailability and Mitigates Rotenone Induced Neurotoxicity in Cell and Drosophila Models of Parkinson's Disease. Neurochem Res 2016;41:3113-28. [PMID: 27535828 DOI: 10.1007/s11064-016-2034-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 3.3] [Reference Citation Analysis]
20 Lundberg AP, Boudreau MW, Selting KA, Chatkewitz LE, Samuelson J, Francis JM, Parkinson EI, Barger AM, Hergenrother PJ, Fan TM. Utilizing feline oral squamous cell carcinoma patients to develop NQO1-targeted therapy. Neoplasia 2021;23:811-22. [PMID: 34246985 DOI: 10.1016/j.neo.2021.06.008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Guha N, Chang JS, Chokkalingam AP, Wiemels JL, Smith MT, Buffler PA. NQO1 polymorphisms and de novo childhood leukemia: a HuGE review and meta-analysis. Am J Epidemiol 2008;168:1221-32. [PMID: 18945694 DOI: 10.1093/aje/kwn246] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 2.9] [Reference Citation Analysis]
22 Liu G, Zhou J, Fu QS, Wang J. The Escherichia coli azoreductase AzoR Is involved in resistance to thiol-specific stress caused by electrophilic quinones. J Bacteriol 2009;191:6394-400. [PMID: 19666717 DOI: 10.1128/JB.00552-09] [Cited by in Crossref: 43] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
23 Gong M, Yi Q, Wang W. Association between NQO1 C609T polymorphism and bladder cancer susceptibility: a systemic review and meta-analysis. Tumour Biol 2013;34:2551-6. [PMID: 23749485 DOI: 10.1007/s13277-013-0799-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
24 Cabello CM, Lamore SD, Bair WB 3rd, Davis AL, Azimian SM, Wondrak GT. DCPIP (2,6-dichlorophenolindophenol) as a genotype-directed redox chemotherapeutic targeting NQO1*2 breast carcinoma. Free Radic Res 2011;45:276-92. [PMID: 21034357 DOI: 10.3109/10715762.2010.526766] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
25 Vasiliou V, Ross D, Nebert DW. Update of the NAD(P)H:quinone oxidoreductase (NQO) gene family. Hum Genomics 2006;2:329-35. [PMID: 16595077 DOI: 10.1186/1479-7364-2-5-329] [Cited by in F6Publishing: 99] [Reference Citation Analysis]
26 Choi EK, Terai K, Ji IM, Kook YH, Park KH, Oh ET, Griffin RJ, Lim BU, Kim JS, Lee DS, Boothman DA, Loren M, Song CW, Park HJ. Upregulation of NAD(P)H:quinone oxidoreductase by radiation potentiates the effect of bioreductive beta-lapachone on cancer cells. Neoplasia 2007;9:634-42. [PMID: 17786182 DOI: 10.1593/neo.07397] [Cited by in Crossref: 56] [Cited by in F6Publishing: 55] [Article Influence: 3.7] [Reference Citation Analysis]
27 Shrishrimal S, Chatterjee A, Kosmacek EA, Davis PJ, McDonald JT, Oberley-Deegan RE. Manganese porphyrin, MnTE-2-PyP, treatment protects the prostate from radiation-induced fibrosis (RIF) by activating the NRF2 signaling pathway and enhancing SOD2 and sirtuin activity. Free Radic Biol Med 2020;152:255-70. [PMID: 32222469 DOI: 10.1016/j.freeradbiomed.2020.03.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
28 Nagata M, Kimura T, Suzumura T, Kira Y, Nakai T, Umekawa K, Tanaka H, Matsuura K, Mitsuoka S, Yoshimura N, Oka T, Kudoh S, Hirata K. C609T Polymorphism of NADPH Quinone Oxidoreductase 1 Correlates Clinical Hematological Toxicities in Lung Cancer Patients Treated with Amrubicin. Clin Med Insights Oncol. 2013;7:31-39. [PMID: 23467445 DOI: 10.4137/cmo.s10839] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
29 Yu H, Liu H, Wang LE, Wei Q. A functional NQO1 609C& gt; T polymorphism and risk of gastrointestinal cancers: a meta-analysis. PLoS One. 2012;7:e30566. [PMID: 22272361 DOI: 10.1371/journal.pone.0030566] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
30 Siegel D, Yan C, Ross D. NAD(P)H:quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones. Biochem Pharmacol 2012;83:1033-40. [PMID: 22209713 DOI: 10.1016/j.bcp.2011.12.017] [Cited by in Crossref: 181] [Cited by in F6Publishing: 170] [Article Influence: 16.5] [Reference Citation Analysis]
31 Meyer ML, Potts-Kant EN, Ghio AJ, Fischer BM, Foster WM, Voynow JA. NAD(P)H quinone oxidoreductase 1 regulates neutrophil elastase-induced mucous cell metaplasia. Am J Physiol Lung Cell Mol Physiol 2012;303:L181-8. [PMID: 22659878 DOI: 10.1152/ajplung.00084.2012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
32 Jobbagy S, Tan RJ. Nitrolipids in kidney physiology and disease. Nitric Oxide 2018:S1089-8603(18)30006-5. [PMID: 29605557 DOI: 10.1016/j.niox.2018.03.021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
33 Huang X, Dong Y, Bey EA, Kilgore JA, Bair JS, Li LS, Patel M, Parkinson EI, Wang Y, Williams NS, Gao J, Hergenrother PJ, Boothman DA. An NQO1 substrate with potent antitumor activity that selectively kills by PARP1-induced programmed necrosis. Cancer Res 2012;72:3038-47. [PMID: 22532167 DOI: 10.1158/0008-5472.CAN-11-3135] [Cited by in Crossref: 90] [Cited by in F6Publishing: 59] [Article Influence: 9.0] [Reference Citation Analysis]
34 Divi RL, Lindeman TL, Shockley ME, Keshava C, Weston A, Poirier MC. Correlation between CYP1A1 transcript, protein level, enzyme activity and DNA adduct formation in normal human mammary epithelial cell strains exposed to benzo[a]pyrene. Mutagenesis 2014;29:409-17. [PMID: 25245543 DOI: 10.1093/mutage/geu049] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
35 Hardwick RN, Fisher CD, Canet MJ, Lake AD, Cherrington NJ. Diversity in antioxidant response enzymes in progressive stages of human nonalcoholic fatty liver disease. Drug Metab Dispos. 2010;38:2293-2301. [PMID: 20805291 DOI: 10.1124/dmd.110.035006] [Cited by in Crossref: 127] [Cited by in F6Publishing: 120] [Article Influence: 10.6] [Reference Citation Analysis]
36 Wondrak GT. NQO1-activated phenothiazinium redox cyclers for the targeted bioreductive induction of cancer cell apoptosis. Free Radic Biol Med 2007;43:178-90. [PMID: 17603928 DOI: 10.1016/j.freeradbiomed.2007.03.035] [Cited by in Crossref: 46] [Cited by in F6Publishing: 44] [Article Influence: 3.1] [Reference Citation Analysis]
37 Xiong R, Siegel D, Ross D. Quinone-induced protein handling changes: implications for major protein handling systems in quinone-mediated toxicity. Toxicol Appl Pharmacol 2014;280:285-95. [PMID: 25151970 DOI: 10.1016/j.taap.2014.08.014] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 4.8] [Reference Citation Analysis]
38 Pinto AV, de Castro SL. The trypanocidal activity of naphthoquinones: a review. Molecules 2009;14:4570-90. [PMID: 19924086 DOI: 10.3390/molecules14114570] [Cited by in Crossref: 135] [Cited by in F6Publishing: 112] [Article Influence: 10.4] [Reference Citation Analysis]
39 Xia N, Daiber A, Förstermann U, Li H. Antioxidant effects of resveratrol in the cardiovascular system. Br J Pharmacol. 2016; Apr 5. [Epub ahead of print]. [PMID: 27058985 DOI: 10.1111/bph.13492] [Cited by in Crossref: 189] [Cited by in F6Publishing: 187] [Article Influence: 31.5] [Reference Citation Analysis]
40 Adler J, Reuven N, Kahana C, Shaul Y. c-Fos proteasomal degradation is activated by a default mechanism, and its regulation by NAD(P)H:quinone oxidoreductase 1 determines c-Fos serum response kinetics. Mol Cell Biol 2010;30:3767-78. [PMID: 20498278 DOI: 10.1128/MCB.00899-09] [Cited by in Crossref: 32] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
41 Chung JE, Chang BC, Lee KE, Kim JH, Gwak HS. Effects of NAD(P)H quinone oxidoreductase 1 polymorphisms on stable warfarin doses in Korean patients with mechanical cardiac valves. Eur J Clin Pharmacol 2015;71:1229-36. [PMID: 26257249 DOI: 10.1007/s00228-015-1915-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
42 Wondrak GT. Redox-directed cancer therapeutics: molecular mechanisms and opportunities. Antioxid Redox Signal 2009;11:3013-69. [PMID: 19496700 DOI: 10.1089/ars.2009.2541] [Cited by in Crossref: 322] [Cited by in F6Publishing: 294] [Article Influence: 26.8] [Reference Citation Analysis]
43 Isaguliants M, Smirnova O, Ivanov AV, Kilpelainen A, Kuzmenko Y, Petkov S, Latanova A, Krotova O, Engström G, Karpov V, Kochetkov S, Wahren B, Starodubova E. Oxidative stress induced by HIV-1 reverse transcriptase modulates the enzyme's performance in gene immunization. Hum Vaccin Immunother 2013;9:2111-9. [PMID: 23881028 DOI: 10.4161/hv.25813] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 3.2] [Reference Citation Analysis]
44 Wang Y, Zhang G, Luo Y. Association between NQO1 C609T polymorphism and colorectal cancer risk. Tumour Biol 2013;34:4027-32. [PMID: 23893397 DOI: 10.1007/s13277-013-0993-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
45 Adamovich Y, Shlomai A, Tsvetkov P, Umansky KB, Reuven N, Estall JL, Spiegelman BM, Shaul Y. The protein level of PGC-1α, a key metabolic regulator, is controlled by NADH-NQO1. Mol Cell Biol 2013;33:2603-13. [PMID: 23648480 DOI: 10.1128/MCB.01672-12] [Cited by in Crossref: 59] [Cited by in F6Publishing: 34] [Article Influence: 6.6] [Reference Citation Analysis]
46 Fu Y, Buryanovskyy L, Zhang Z. Quinone reductase 2 is a catechol quinone reductase. J Biol Chem 2008;283:23829-35. [PMID: 18579530 DOI: 10.1074/jbc.M801371200] [Cited by in Crossref: 43] [Cited by in F6Publishing: 17] [Article Influence: 3.1] [Reference Citation Analysis]
47 Mihasan M, Chiribau CB, Friedrich T, Artenie V, Brandsch R. An NAD(P)H-nicotine blue oxidoreductase is part of the nicotine regulon and may protect Arthrobacter nicotinovorans from oxidative stress during nicotine catabolism. Appl Environ Microbiol 2007;73:2479-85. [PMID: 17293530 DOI: 10.1128/AEM.02668-06] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
48 Voynow JA, Fischer BM, Zheng S, Potts EN, Grover AR, Jaiswal AK, Ghio AJ, Foster WM. NAD(P)H quinone oxidoreductase 1 is essential for ozone-induced oxidative stress in mice and humans. Am J Respir Cell Mol Biol 2009;41:107-13. [PMID: 19059883 DOI: 10.1165/rcmb.2008-0381OC] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
49 Covarrubias VG, Lakhman SS, Forrest A, Relling MV, Blanco JG. Higher activity of polymorphic NAD(P)H:quinone oxidoreductase in liver cytosols from blacks compared to whites. Toxicol Lett 2006;164:249-58. [PMID: 16478651 DOI: 10.1016/j.toxlet.2006.01.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
50 Mayor T, Sharon M, Glickman MH. Tuning the proteasome to brighten the end of the journey. Am J Physiol Cell Physiol 2016;311:C793-804. [PMID: 27605452 DOI: 10.1152/ajpcell.00198.2016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
51 Alard A, Fabre B, Anesia R, Marboeuf C, Pierre P, Susini C, Bousquet C, Pyronnet S. NAD(P)H quinone-oxydoreductase 1 protects eukaryotic translation initiation factor 4GI from degradation by the proteasome. Mol Cell Biol 2010;30:1097-105. [PMID: 20028737 DOI: 10.1128/MCB.00868-09] [Cited by in Crossref: 28] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
52 Li LS, Bey EA, Dong Y, Meng J, Patra B, Yan J, Xie XJ, Brekken RA, Barnett CC, Bornmann WG, Gao J, Boothman DA. Modulating endogenous NQO1 levels identifies key regulatory mechanisms of action of β-lapachone for pancreatic cancer therapy. Clin Cancer Res 2011;17:275-85. [PMID: 21224367 DOI: 10.1158/1078-0432.CCR-10-1983] [Cited by in Crossref: 83] [Cited by in F6Publishing: 40] [Article Influence: 7.5] [Reference Citation Analysis]
53 Wu YT, Lin CY, Tsai MY, Chen YH, Lu YF, Huang CJ, Cheng CM, Hwang SP. β-Lapachone induces heart morphogenetic and functional defects by promoting the death of erythrocytes and the endocardium in zebrafish embryos. J Biomed Sci 2011;18:70. [PMID: 21936955 DOI: 10.1186/1423-0127-18-70] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
54 Ahn KJ, Lee HS, Bai SK, Song CW. Enhancement of radiation effect using beta-lapachone and underlying mechanism. Radiat Oncol J 2013;31:57-65. [PMID: 23865001 DOI: 10.3857/roj.2013.31.2.57] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
55 Mohan N, Sudheesh AP, Francis N, Anderson R, Laishram RS. Phosphorylation regulates the Star-PAP-PIPKIα interaction and directs specificity toward mRNA targets. Nucleic Acids Res 2015;43:7005-20. [PMID: 26138484 DOI: 10.1093/nar/gkv676] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
56 Chen Y, Liang J, Liang X, Chen J, Wang Y, Cao J, Sun C, Ye J, Chen Q. Limonin induces apoptosis of HL-60 cells by inhibiting NQO1 activity. Food Sci Nutr 2021;9:1860-9. [PMID: 33841805 DOI: 10.1002/fsn3.2109] [Reference Citation Analysis]
57 Dinkova-Kostova AT, Talalay P. NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector. Arch Biochem Biophys 2010;501:116-23. [PMID: 20361926 DOI: 10.1016/j.abb.2010.03.019] [Cited by in Crossref: 440] [Cited by in F6Publishing: 417] [Article Influence: 36.7] [Reference Citation Analysis]
58 Ray JG, Mukherjee S, Pattanayak Mohanty S, Chaudhuri K. Oral verrucous carcinoma--a misnomer? Immunohistochemistry based comparative study of two cases. BMJ Case Rep 2011;2011:bcr1120103479. [PMID: 22696703 DOI: 10.1136/bcr.11.2010.3479] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
59 Boddupalli S, Mein JR, Lakkanna S, James DR. Induction of phase 2 antioxidant enzymes by broccoli sulforaphane: perspectives in maintaining the antioxidant activity of vitamins a, C, and e. Front Genet 2012;3:7. [PMID: 22303412 DOI: 10.3389/fgene.2012.00007] [Cited by in Crossref: 57] [Cited by in F6Publishing: 57] [Article Influence: 5.7] [Reference Citation Analysis]
60 Zhang TT, Qu N, Sun GH, Zhang L, Wang YJ, Mu XM, Wei WJ, Wang YL, Wang Y, Ji QH, Zhu YX, Shi RL. NRG1 regulates redox homeostasis via NRF2 in papillary thyroid cancer. Int J Oncol 2018;53:685-93. [PMID: 29901070 DOI: 10.3892/ijo.2018.4426] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
61 Wang Y, Qi W, Zhang L, Ying Z, Sha O, Li C, Lü L, Chen X, Li Z, Niu F, Xue F, Wang D, Ng TB, Zhang L. The novel targets of DL-3-n-butylphthalide predicted by similarity ensemble approach in combination with molecular docking study. Quant Imaging Med Surg 2017;7:532-6. [PMID: 29184765 DOI: 10.21037/qims.2017.10.08] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
62 Infante-Rivard C, Vermunt JK, Weinberg CR. Excess transmission of the NAD(P)H:quinone oxidoreductase 1 (NQO1) C609T polymorphism in families of children with acute lymphoblastic leukemia. Am J Epidemiol 2007;165:1248-54. [PMID: 17332311 DOI: 10.1093/aje/kwm022] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 1.9] [Reference Citation Analysis]
63 Guise CP, Mowday AM, Ashoorzadeh A, Yuan R, Lin WH, Wu DH, Smaill JB, Patterson AV, Ding K. Bioreductive prodrugs as cancer therapeutics: targeting tumor hypoxia. Chin J Cancer 2014;33:80-6. [PMID: 23845143 DOI: 10.5732/cjc.012.10285] [Cited by in Crossref: 93] [Cited by in F6Publishing: 89] [Article Influence: 10.3] [Reference Citation Analysis]
64 Kummarapurugu AB, Fischer BM, Zheng S, Milne GL, Ghio AJ, Potts-Kant EN, Foster WM, Soderblom EJ, Dubois LG, Moseley MA, Thompson JW, Voynow JA. NADPH:quinone oxidoreductase 1 regulates host susceptibility to ozone via isoprostane generation. J Biol Chem 2013;288:4681-91. [PMID: 23275341 DOI: 10.1074/jbc.M112.438440] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
65 Atiomo W, Shafiee MN, Chapman C, Metzler VM, Abouzeid J, Latif A, Chadwick A, Kitson S, Sivalingam VN, Stratford IJ, Rutland CS, Persson JL, Ødum N, Fuentes-Utrilla P, Jeyapalan JN, Heery DM, Crosbie EJ, Mongan NP. Expression of NAD(P)H quinone dehydrogenase 1 (NQO1) is increased in the endometrium of women with endometrial cancer and women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 2017;87:557-65. [PMID: 28748640 DOI: 10.1111/cen.13436] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
66 Nemeikaitė-Čėnienė A, Šarlauskas J, Misevičienė L, Marozienė A, Jonušienė V, Lesanavičius M, Čėnas N. Aerobic Cytotoxicity of Aromatic N-Oxides: The Role of NAD(P)H:Quinone Oxidoreductase (NQO1). Int J Mol Sci 2020;21:E8754. [PMID: 33228195 DOI: 10.3390/ijms21228754] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
67 Froeling FEM, Swamynathan MM, Deschênes A, Chio IIC, Brosnan E, Yao MA, Alagesan P, Lucito M, Li J, Chang AY, Trotman LC, Belleau P, Park Y, Rogoff HA, Watson JD, Tuveson DA. Bioactivation of Napabucasin Triggers Reactive Oxygen Species-Mediated Cancer Cell Death. Clin Cancer Res 2019;25:7162-74. [PMID: 31527169 DOI: 10.1158/1078-0432.CCR-19-0302] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
68 Zhou W, Dowell DR, Geraci MW, Blackwell TS, Collins RD, Polosukhin VV, Lawson WE, Wu P, Sussan T, Biswal S, Goleniewska K, O'Neal J, Newcomb DC, Toki S, Morrow JD, Peebles RS Jr. PGI synthase overexpression protects against bleomycin-induced mortality and is associated with increased Nqo 1 expression. Am J Physiol Lung Cell Mol Physiol 2011;301:L615-22. [PMID: 21764988 DOI: 10.1152/ajplung.00224.2010] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
69 Cui X, Li L, Yan G, Meng K, Lin Z, Nan Y, Jin G, Li C. High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma. BMC Cancer 2015;15:244. [PMID: 25885439 DOI: 10.1186/s12885-015-1271-4] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 5.0] [Reference Citation Analysis]
70 Gaikwad NW, Rogan EG, Cavalieri EL. Evidence from ESI-MS for NQO1-catalyzed reduction of estrogen ortho-quinones. Free Radic Biol Med. 2007;43:1289-1298. [PMID: 17893042 DOI: 10.1016/j.freeradbiomed.2007.07.02] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
71 Zhang R, Xu M, Wang Y, Xie F, Zhang G, Qin X. Nrf2—a Promising Therapeutic Target for Defensing Against Oxidative Stress in Stroke. Mol Neurobiol 2017;54:6006-17. [DOI: 10.1007/s12035-016-0111-0] [Cited by in Crossref: 93] [Cited by in F6Publishing: 100] [Article Influence: 15.5] [Reference Citation Analysis]
72 Rao VA, Klein SR, Bonar SJ, Zielonka J, Mizuno N, Dickey JS, Keller PW, Joseph J, Kalyanaraman B, Shacter E. The antioxidant transcription factor Nrf2 negatively regulates autophagy and growth arrest induced by the anticancer redox agent mitoquinone. J Biol Chem 2010;285:34447-59. [PMID: 20805228 DOI: 10.1074/jbc.M110.133579] [Cited by in Crossref: 91] [Cited by in F6Publishing: 63] [Article Influence: 7.6] [Reference Citation Analysis]
73 Tsvetkov P, Adamovich Y, Elliott E, Shaul Y. E3 ligase STUB1/CHIP regulates NAD(P)H:quinone oxidoreductase 1 (NQO1) accumulation in aged brain, a process impaired in certain Alzheimer disease patients. J Biol Chem 2011;286:8839-45. [PMID: 21220432 DOI: 10.1074/jbc.M110.193276] [Cited by in Crossref: 45] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
74 Cabello CM, Bair WB 3rd, Bause AS, Wondrak GT. Antimelanoma activity of the redox dye DCPIP (2,6-dichlorophenolindophenol) is antagonized by NQO1. Biochem Pharmacol 2009;78:344-54. [PMID: 19394313 DOI: 10.1016/j.bcp.2009.04.016] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.3] [Reference Citation Analysis]
75 Hallgren KW, Qian W, Yakubenko AV, Runge KW, Berkner KL. r-VKORC1 expression in factor IX BHK cells increases the extent of factor IX carboxylation but is limited by saturation of another carboxylation component or by a shift in the rate-limiting step. Biochemistry 2006;45:5587-98. [PMID: 16634640 DOI: 10.1021/bi051986y] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
76 Madajewski B, Boatman MA, Chakrabarti G, Boothman DA, Bey EA. Depleting Tumor-NQO1 Potentiates Anoikis and Inhibits Growth of NSCLC. Mol Cancer Res 2016;14:14-25. [PMID: 26553038 DOI: 10.1158/1541-7786.MCR-15-0207-T] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
77 Liu F, Yu G, Wang G, Liu H, Wu X, Wang Q, Liu M, Liao K, Wu M, Cheng X, Hao H. An NQO1-initiated and p53-independent apoptotic pathway determines the anti-tumor effect of tanshinone IIA against non-small cell lung cancer. PLoS One 2012;7:e42138. [PMID: 22848731 DOI: 10.1371/journal.pone.0042138] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 5.8] [Reference Citation Analysis]
78 Lewis JE, Costantini F, Mims J, Chen X, Furdui CM, Boothman DA, Kemp ML. Genome-Scale Modeling of NADPH-Driven β-Lapachone Sensitization in Head and Neck Squamous Cell Carcinoma. Antioxid Redox Signal 2018;29:937-52. [PMID: 28762750 DOI: 10.1089/ars.2017.7048] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
79 Whibley C, Pharoah PD, Hollstein M. p53 polymorphisms: cancer implications. Nat Rev Cancer. 2009;9:95-107. [PMID: 19165225 DOI: 10.1038/nrc2584] [Cited by in Crossref: 427] [Cited by in F6Publishing: 394] [Article Influence: 32.8] [Reference Citation Analysis]
80 Bentle MS, Bey EA, Dong Y, Reinicke KE, Boothman DA. New tricks for old drugs: the anticarcinogenic potential of DNA repair inhibitors. J Mol Histol 2006;37:203-18. [PMID: 16868862 DOI: 10.1007/s10735-006-9043-8] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 3.3] [Reference Citation Analysis]
81 Figueira I, Tavares L, Jardim C, Costa I, Terrasso AP, Almeida AF, Govers C, Mes JJ, Gardner R, Becker JD, McDougall GJ, Stewart D, Filipe A, Kim KS, Brites D, Brito C, Brito MA, Santos CN. Blood-brain barrier transport and neuroprotective potential of blackberry-digested polyphenols: an in vitro study. Eur J Nutr 2019;58:113-30. [PMID: 29151137 DOI: 10.1007/s00394-017-1576-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
82 Ding R, Lin S, Chen D. Association of NQO1 rs1800566 polymorphism and the risk of colorectal cancer: a meta-analysis. Int J Colorectal Dis 2012;27:885-92. [PMID: 22215148 DOI: 10.1007/s00384-011-1396-0] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
83 Gaikwad NW, Rogan EG, Cavalieri EL. Evidence from ESI-MS for NQO1-catalyzed reduction of estrogen ortho-quinones. Free Radic Biol Med 2007;43:1289-98. [PMID: 17893042 DOI: 10.1016/j.freeradbiomed.2007.07.021] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 4.0] [Reference Citation Analysis]
84 Wolfová J, Mesters JR, Brynda J, Grandori R, Natalello A, Carey J, Kutá Smatanová I. Crystallization and preliminary diffraction analysis of Escherichia coli WrbA in complex with its cofactor flavin mononucleotide. Acta Crystallogr Sect F Struct Biol Cryst Commun 2007;63:571-5. [PMID: 17620713 DOI: 10.1107/S1744309107026103] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
85 Bey EA, Bentle MS, Reinicke KE, Dong Y, Yang CR, Girard L, Minna JD, Bornmann WG, Gao J, Boothman DA. An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone. Proc Natl Acad Sci USA. 2007;104:11832-11837. [PMID: 17609380 DOI: 10.1073/pnas.0702176104] [Cited by in Crossref: 244] [Cited by in F6Publishing: 232] [Article Influence: 16.3] [Reference Citation Analysis]
86 Tian L, Xiao P, Zhou B, Chen Y, Kang L, Wang Q, Lin J, Son M, Wu Q. Influence of NQO1 Polymorphisms on Warfarin Maintenance Dose: A Systematic Review and Meta-Analysis (rs1800566 and rs10517). Cardiovasc Ther 2021;2021:5534946. [PMID: 34457036 DOI: 10.1155/2021/5534946] [Reference Citation Analysis]
87 Cleton-Jansen AM, van Eijk R, Lombaerts M, Schmidt MK, Van't Veer LJ, Philippo K, Zimmerman RM, Peterse JL, Smit VT, van Wezel T, Cornelisse CJ. ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism. BMC Cancer 2008;8:105. [PMID: 18416817 DOI: 10.1186/1471-2407-8-105] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
88 Yang Y, Zhou X, Xu M, Piao J, Zhang Y, Lin Z, Chen L. β-lapachone suppresses tumour progression by inhibiting epithelial-to-mesenchymal transition in NQO1-positive breast cancers. Sci Rep 2017;7:2681. [PMID: 28578385 DOI: 10.1038/s41598-017-02937-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 4.0] [Reference Citation Analysis]
89 Sydor JR, Normant E, Pien CS, Porter JR, Ge J, Grenier L, Pak RH, Ali JA, Dembski MS, Hudak J. Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90. Proc Natl Acad Sci USA. 2006;103:17408-17413. [PMID: 17090671 DOI: 10.1073/pnas.0608372103] [Cited by in Crossref: 168] [Cited by in F6Publishing: 138] [Article Influence: 10.5] [Reference Citation Analysis]
90 Onyenwoke RU, Geyer R, Wiegel J. Characterization of a soluble oxidoreductase from the thermophilic bacterium Carboxydothermus ferrireducens. Extremophiles 2009;13:687-93. [PMID: 19536454 DOI: 10.1007/s00792-009-0255-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
91 Lienhart WD, Strandback E, Gudipati V, Koch K, Binter A, Uhl MK, Rantasa DM, Bourgeois B, Madl T, Zangger K, Gruber K, Macheroux P. Catalytic competence, structure and stability of the cancer-associated R139W variant of the human NAD(P)H:quinone oxidoreductase 1 (NQO1). FEBS J 2017;284:1233-45. [PMID: 28236663 DOI: 10.1111/febs.14051] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]